© 2005 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Vipul Patel, M.D., who specializes in treating prostate and kidney cancers, is joining the Ohio State University Medical Center in Columbus to direct its Robotics and Minimally Invasive Urological Surgery Program.
The Institute of Medicine has appointed 22 members to its new National Cancer Policy Forum, which replaces the National Cancer Policy Board, including Hal Moses, M.D., director emeritus of the Vanderbilt Ingram Cancer Center in Nashville, Tenn., who will be the chair. Other members are as follows: Edward Benz, M.D., Dana-Farber Cancer Center, Boston; Kevin Brady, M.P.H., Centers for Disease Control and Prevention; Thomas Burish, Ph.D., Washington and Lee University, Lexington, Va.; Mark Clanton, M.D., National Cancer Institute; Connie Curran, Ed.D., C-Change; Betty Ferrell, Ph.D., R.N., City of Hope National Medical Center, Duarte, Calif.; Stephen Friend, M.D., Ph.D., Merck; Patricia Ganz, M.D., University of California, Los Angeles; William Lawrence, M.D., Agency for Healthcare Research and Quality; Lynn Matrisian, Ph.D., Vanderbilt University, Nashville, Tenn.; William McGuire, M.D., UnitedHealth Group; David Parkinson, M.D., Amgen; Edith Perez, M.D., Mayo Clinic, Rochester, Minn.; Scott Ramsey, M.D., Ph.D., Fred Hutchinson Cancer Research Center, Seattle; William Robinson, M.D., Department of Health and Human Services; Charles Sawyers, M.D., University of California, Los Angeles; Margaret Spitz, M.D., University of Texas M. D. Anderson Cancer Center, Houston; Ellen Stovall, National Coalition for Cancer Survivorship; Sean Tunis, M.D., Centers for Medicaid and Medicare Services (alternate: Peter Bach, M.D.); Janet Woodcock, M.D., U.S. Food and Drug Administration.
Jefferson Medical College of Thomas Jefferson University in Philadelphia has made several appointments:
Scott A. Waldman, M.D., Ph.D., Samuel M.V. Hamilton Family Professor of Medicine, has been named chair of the new department of pharmacology and experimental therapeutics. Waldman is a member of Jefferson's Kimmel Cancer Center and is director of the division of clinical pharmacology in the department of medicine at the medical college.
Jeffrey L. Benovic, Ph.D., professor of biochemistry and molecular biology and interim deputy director of the Kimmel Cancer Center, has been named chair of the newly restructured department of biochemistry and molecular biology.
Tim Manser, Ph.D., has been named chair of the department of microbiology and immunology. Manser, professor of microbiology and immunology, has been the leader of the immunology program at the Kimmel Cancer Center since 2000.
The U.S. Food and Drug Administration has announced several personnel changes.
Steven Galson, M.D., M.P.H., has been named the permanent director of the Center for Drug Evaluation and Research.
Scott Gottlieb, M.D., will be the new Deputy Commissioner for Medical and Scientific Affairs.
Janet Woodcock, M.D., has been named the Deputy Commissioner for Operations and Chief Operating Officer on a permanent basis.
Murray M. Lumpkin, M.D., will become Deputy Commissioner for International and Special Programs, also on a permanent basis.
The Association for Research in Vision and Ophthalmology has announced that that Evangelos S. Gragoudas, M.D., will receive ARVO's 2006 Weisenfeld Award at the group's annual meeting next May. Gragoudas, director of the retina service at the Massachusetts Eye and Ear Infirmary in Boston, is being honored for his achievement in the use of beam irradiation in the treatment of intraocular melanoma and for the development of photodynamic therapy for neovascular age-related macular degeneration.
St. Jude Children's Research Hospital in Memphis, Tenn., has announced the appointment of three cancer researchers.
Douglas R. Green, Ph.D., will head the department of immunology and lead a new initiative for integrating immune system research into ongoing efforts to improve the diagnosis and treatment of childhood catastrophic diseases.
Rodney Kiplin Guy, Ph.D., will head the new department of chemical biology and therapeutics, which will study the molecular basis of childhood catastrophic diseases and develop new drugs to treat them.
Leslie L. Robison, Ph.D., will head the new department of epidemiology and cancer control.
Francis J. Mahoney, Ph.D., program director for radiation and chief of the radiotherapy development branch in the division of cancer treatment at the National Cancer Institute, has been named an honorary member in the American Society for Therapeutic Radiology and Oncology. Mahoney will receive his award at the society's annual meeting in October.
The Nevada Cancer Institute in Las Vegas has added two clinicians to its operations: Anita Pomerantz, M.D., will be co-director of radiation oncology clinical research, and David Pomerantz, M.D., will be co-director of radiation oncology clinical operations.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||